COMPANY PROFILE
Your Trusted CDMO Partner for Small Molecules and Cell & Gene Therapies
Strategic Quote
“It is important to continue to be at the forefront providing a reliable supply of material to the clinic and patients. AFC / SK pharmteco continues to invest in capabilities that support our customers with materials from grams up to metric tons.” Jeff Butler, PhD, President, AMPAC Fine Chemicals
Summary
SK pharmteco is a global CDMO specializing in the clinical to commercial production of APIs, Advanced Intermediates, and Cell and Gene Therapies. Headquartered in California, SK Pharmteco (SKPT) operates 7 manufacturing sites and 3 analytical sites across the US, Europe, and Asia with ~1,000 m³ of small molecule capacity and ~10,000 m² of large molecule facilities. Our vision is to be the most trusted global partner in the delivery of innovative medicine.
Our offerings include process R&D, analytical testing, scale-up and optimization, validation, and commercial production. Built on over 75 years of experience, we have expertise in energetic chemistry, continuous flow processing, chromatography, high potency, particle engineering, and AVV and lentiviral vectors.
We have a strong record of safety, health, and environmental performance. Our plants have been successfully audited by global regulatory agencies including the FDA (US), EMA (Europe), PMDA (Japan), and MFDS (Korea).
To learn how we can support your next project, contact us at skpharmteco@sk.com
Key Leadership
- Joerg Ahlgrimm, CEO, SK pharmteco
- David Lowndes, COO, SK pharmteco
- Yongwoo Park, CSO, SK pharmteco
- Alain Lamproye, CEO, Yposkesi
- Jeff Butler, President, AMPAC Fine Chemicals
- Joyce Fitzharris, President, SK biotek Ireland
- Keun-Joo Hwang, CEO, SK biotek Korea
- Chris Conley, VP Global SH&E / HR, SK pharmteco
- Larry Zeagler, VP Global Legal / Contracts, SK pharmteco
- Minsoo Hong, VP Finance, SK pharmteco
- Patrick Park, VP Marketing, External Communications, and M&A, SK pharmteco
- Conrad Hummel, VP Business Development (US), SK pharmteco
- Jaeyon Yoon, VP Business Development (Asia, US), SK pharmteco
- Steve Barr, VP Business Development (Europe), SK pharmteco
Key Capabilities and Services:
- Energetic Chemistry
- Continuous Flow Processing
- Chromatography (Batch & SMB)
- High Potency
- Particle Engineering, Spray Drying, & Micronization
- Viral Vector Development & Manufacturing
- Analytical Services
- Linkers & Payloads
- Oligonucleotides